Andrew Salzman

CEO

Equibles does not estimate personal net worth.

About Andrew Salzman

Andrew Salzman is recorded as CEO at Metagenomi Therapeutics, Inc. (MGX). Andrew Salzman has spoken on 1 investor event across 1 company, most recently for Metagenomi Therapeutics, Inc. on October 20, 2026. Metagenomi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Metagenomi Therapeutics, Inc. includes Jian Irish (CEO, COO and Board Member), Pamela Wapnick (CFO), Matthew L. Wein (General Counsel) and 6 others.

Andrew Salzman on recent calls

“Just to add, we don't just methylate or methylate. We do histone acetylation. We basically regulate genes up and down. So as you noted, the work that was done by the Nobel laureates for CRISPR was amazing.”

CEO, Chardan 10th Annual Healthcare Conference · October 20, 2026